2008-04-22 22:48:12 - Dan Fitzpatrick, Director of Medical Sciences at Amgen to Present at GTCbio's 2nd Annual Rediscovering Biomarkers on July 10-11, 2008 in Boston, MA

MONROVIA, CA - Dr. Dan Fitzpatrick, Director of Medical Sciences at Amgen will be speaking at GTCbio's 2nd Annual Rediscovering Biomarkers on July 10-11, 2008 in Boston, MA. Dr. Fitzpatrick will present on 'Biomarker Sample Collection & Handling: the Phantom Menace.'
The disparate - and often novel - sample types employed in pharmacodynamic biomarker strategies are saddled with their own unique

sources of preanalytical variance. Several case studies will be presented demonstrating some of these sources of variance and our own resolution of the issues. A perspective will be provided on developing a consolidated approach to tackling what are effectively a series of case-by-case obstacles.
The 2nd Annual Rediscovering Biomarkers Conference will expose attendees to the latest advancements and developments in biomarkers and predictive medicine. Attendees will gain insight into discovery and development processes, hear about new biomarkers and upcoming trends in the industry, as well as the status of those in clinical trials. Delegates will also receive highly valuable information on tools for improving reimbursement strategies and the efficacy and validation of biomarkers.

For more information including a detailed agenda, exhibitor opportunities and registration information visit gtcbio.com/conferenceDetails.aspx?id=124
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com